Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Triggers typically occur when portfolio drift exceeds a set threshold or on a scheduled interval, prompting a rebalance to restore targets.
15,940 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Oil sits below $76. bitcoin still baffles many investors as cryptocurrency momentum and macro trends diverge. This gu...
Berkshire Hathaway's Bank of America stake remains a defining part of its portfolio, even as the company reshapes its...
Bitcoin has sparked doom-and-gloom headlines for years. This honest assessment digs into whether bitcoin going here's...
A fresh market mood is emerging: gold funds are losing steam while Bitcoin ETFs gain traction. This article breaks do...
Regulators scrutinize exchange activity amid sanction challenges. This article breaks down CoinEx's denial, the fund ...
When a CEO sells shares, investors watch closely. This piece breaks down Exponent's move by Catherine Corrigan, expla...
Dogecoin's slump continues with another dip, underscoring the volatility of meme coins. This guide breaks down why th...
A Goldman Sachs analysis argues the Iran conflict will lift energy prices but is unlikely to trigger a broad global s...
As the calendar flips to May, many investors rethink risk. This guide shows three cryptocurrencies to unload before s...
Estonia is weighing a radical step: giving AI agents their own national IDs, separate from their human owners. This a...
Old Dominion Freight Line (ODFL) faced an 11.9% drop after a Citi downgrade, despite strong fundamentals. This articl...